tiprankstipranks
Charles River Laboratories Intl (CRL)
NYSE:CRL
US Market
Holding CRL?
Track your performance easily

Charles River Labs (CRL) Ownership - Who Owns Charles River Labs?

522 Followers

Charles River Labs (CRL) Ownership Overview

0.94%31.98%0.47%24.87%41.73%
0.47% Other Institutional Investors
24.87% ETFs
41.73% Public Companies and Individual Investors
The ownership structure of Charles River Labs (CRL) stock is a mix of institutional, retail, and individual investors. Approximately 57.32% of the company’s stock is owned by Institutional Investors, 0.94% is owned by Insiders, and 41.73% is owned by Public Companies and Individual Investors.
The ownership structure of Charles River Labs (CRL) stock is a mix of institutional, retail, and individual investors. Approximately 32.46% of the company’s stock is owned by Institutional Investors, 0.94% is owned by Insiders, and 24.87% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 12, 2024
xxxxxxxxxxxxx
$1647418
Aug 12, 2024
Joseph W Laplume
Evp, Corp Strategy & Develop
xxxxxxxxxxxxx
$354861
May 14, 2024
Joseph W Laplume
Evp, Corp Strategy & Develop
xxxxxxxxxxxxx
$295969
Mar 11, 2024
Michael Gunnar Knell
Csvp&chief Accounting Officer
xxxxxxxxxxxxx
$216156

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,471,997Institution10.70%951,634,998
4,998,573Institution9.78%869,301,830
2,442,260Institution4.78%424,733,437
1,999,115Institution3.91%347,666,090
1,877,324Institution3.67%326,485,417
1,443,049Institution2.82%250,960,652
1,097,981Institution2.15%190,949,876
1,003,472Institution1.96%174,513,816
932,186Institution1.82%162,116,467
897,687Institution1.76%156,116,746

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,998,573Institution9.78%869,301,830
1,999,115Institution3.91%347,666,090
1,443,049Institution2.82%250,960,652
932,186Institution1.82%162,116,467
836,664Institution1.64%145,504,236
670,861Institution1.31%116,669,437
410,461Institution0.80%71,383,273
368,785Institution0.72%64,135,399
357,667Institution0.70%62,201,868
326,018Institution0.64%56,697,790

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,622,788Institution3.17%323,032,179
1,387,899Institution2.71%276,275,175
1,302,804Institution2.55%259,336,164
775,595Institution1.52%134,883,726
716,954Institution1.40%142,716,863
636,350Institution1.24%110,667,629
635,570Institution1.24%113,182,306
600,426Institution1.17%104,420,086
377,114Institution0.74%67,156,461
323,019Institution0.63%56,176,234

FAQ

Who Owns Charles River Laboratories Intl (CRL)?
According to the latest TipRanks data, approximately 0.47% of the company's stock is held by institutional investors, 0.94% is held by insiders, and 41.73% is held by retail investors.
    What percentage of Charles River Laboratories Intl (CRL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.47% of Charles River Laboratories Intl (CRL) stock is held by institutional investors.
      What percentage of Charles River Laboratories Intl (CRL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 41.73% of Charles River Laboratories Intl (CRL) stock is held by retail investors.
        Who owns the most shares of Charles River Laboratories Intl (CRL)?
        Vanguard owns the most shares of Charles River Laboratories Intl (CRL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis